{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:45:52Z","timestamp":1740141952814,"version":"3.37.3"},"reference-count":53,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100000780","name":"European Union\u2019s Horizon 2020 research and innovation program","doi-asserted-by":"publisher","award":["813284"],"award-info":[{"award-number":["813284"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>During the past two decades, many nicotinamide phosphoribosyltransferase\n(NAMPT) inhibitors were prepared and tested because this enzyme is overexpressed in pancreatic\ncancer. Although FK866 is a well-known, strong NAMPT inhibitor, it suffers severe drawbacks.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Our work aimed to synthesize efficient NAMPT inhibitors featuring better pharmacokinetic\nproperties than the pyridine-containing FK866. To this aim, the new anticancer agents were\nbased on benzene, pyridazine, or benzothiazole moieties as a cap group instead of the pyridine unit\nfound in FK866 and other NAMPT inhibitors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The new compounds, prepared exploiting standard heterocycle chemistry and coupling\nreactions (e.g., formation of amides, ureas, and cyanoguanidines, copper-mediated azide-alkyne\ncycloaddition), have been fully characterized using NMR and HRMS analyses. Their activity has\nbeen evaluated using cytotoxicity and intracellular NAD depletion assays in the human pancreatic\ncancer cell line MiaPaCa-2.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Among the 14 products obtained, compound 28, bearing a pyridazine unit as the cap group\nand a thiophene moiety as the tail group, showed 6.7 nanomolar inhibition activity in the intracellular\nNAD depletion assay and 43 nanomolar inhibition in the MiaPaCa-2 cells cytotoxicity assay,\ncomparable to that observed for FK866.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The positive results observed for some newly synthesized molecules, particularly\nthose carrying a thiophene unit as a tail group, indicate that they could act as in vivo anti-pancreatic\ncancer agents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115734064289584240121142405","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T09:53:36Z","timestamp":1707472416000},"page":"694-708","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Analogues of the Nicotinamide Phosphoribosyltransferase Inhibitor\nFK866 as Potential Anti-Pancreatic Cancer Agents"],"prefix":"10.2174","volume":"20","author":[{"given":"Irene","family":"Conforti","sequence":"first","affiliation":[{"name":"Institut des Biomol\u00e9cules Max Mousseron (IBMM, UMR 5247), Universit\u00e9 de Montpellier, P\u00f4le Chimie Balard Recherche, 1919 Route de Mende, 34293 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Benzi","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Sperimentale-DIMES, Scuola di\nScienze Mediche e Farmaceutiche, Universit\u00e0 degli Studi di Genova, Viale Benedetto XV 1, 16132 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Caffa","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Interna e Specialit\u00e0 Mediche-DIMI, Universit\u00e0 degli Studi di Genova, Viale Benedetto XV 6,\n16132 Genova, Italy"},{"name":"IRCCS, Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santina","family":"Bruzzone","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Sperimentale-DIMES, Scuola di\nScienze Mediche e Farmaceutiche, Universit\u00e0 degli Studi di Genova, Viale Benedetto XV 1, 16132 Genova, Italy"},{"name":"IRCCS, Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Nencioni","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Interna e Specialit\u00e0 Mediche-DIMI, Universit\u00e0 degli Studi di Genova, Viale Benedetto XV 6,\n16132 Genova, Italy"},{"name":"IRCCS, Ospedale Policlinico San Martino, 16132 Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-2100","authenticated-orcid":true,"given":"Alberto","family":"Marra","sequence":"additional","affiliation":[{"name":"Institut des Biomol\u00e9cules Max Mousseron (IBMM, UMR 5247), Universit\u00e9 de Montpellier, P\u00f4le Chimie Balard Recherche,\n1919 Route de Mende, 34293 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"Park W.","year":"2021","unstructured":"Park W.; Chawla A.; O\u2019Reilly E.M.; Pancreatic cancer. JAMA  2021,326(9),851-862","journal-title":"JAMA"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/ijo.2022.5383","volume":"61","author":"Zuz\u010d\u00e1k M.","year":"2022","unstructured":"Zuz\u010d\u00e1k M.; Trnka J.; Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment. Int J Oncol  2022,61(2),93","journal-title":"Int J Oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.21037\/jgo-22-763","volume":"14","author":"Fernandes E.S.M.","year":"2023","unstructured":"Fernandes E.S.M.; de Mello F.P.T.; Braga E.P.; de Souza G.O.; Andrade R.; Pimentel L.S.; Gir\u00e3o C.L.; Siqueira M.; Moraes-Junior J.M.A.; de Oliveira R.V.; Goldaracena N.; Torres O.J.M.; A more radical perspective on surgical approach and outcomes in pancreatic cancer-a narrative review. J Gastrointest Oncol  2023,14(4),1964-1981","journal-title":"J Gastrointest Oncol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s10620-023-07904-6","volume":"68","author":"Amaral M.J.","year":"2023","unstructured":"Amaral M.J.; Oliveira R.C.; Donato P.; Tralh\u00e3o J.G.; Pancreatic cancer biomarkers: Oncogenic mutations, tissue and liquid biopsies, and radiomics-A review. Dig Dis Sci  2023,68(7),2811-2823","journal-title":"Dig Dis Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e44248","DOI":"10.2196\/44248","volume":"25","author":"Jan Z.","year":"2023","unstructured":"Jan Z.; El Assadi F.; Abd-alrazaq A.; Jithesh P.V.; Artificial intelligence for the prediction and early diagnosis of pancreatic cancer: Scoping review. J Med Internet Res  2023,25,e44248","journal-title":"J Med Internet Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"154438","DOI":"10.1016\/j.prp.2023.154438","volume":"245","author":"Al-Noshokaty T.M.","year":"2023","unstructured":"Al-Noshokaty T.M.; Mansour A.; Abdelhamid R.; Abdellatif N.; Alaaeldien A.; Reda T.; Abdelmaksoud N.M.; Doghish A.S.; Abulsoud A.I.; Elshaer S.S.; Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. Pathol Res Pract  2023,245,154438","journal-title":"Pathol Res Pract"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/metabo13070872","volume":"13","author":"Perazzoli G.","year":"2023","unstructured":"Perazzoli G.; Garc\u00eda-Valdeavero O.M.; Pe\u00f1a M.; Prados J.; Melguizo C.; Jim\u00e9nez-Luna C.; Evaluating metabolite-based biomarkers for early diagnosis of pancreatic cancer: A systematic review. Metabolites  2023,13(7),872","journal-title":"Metabolites"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/biomedicines11102690","volume":"11","author":"Mazur R.","year":"2023","unstructured":"Mazur R.; Trna J.; Principles of palliative and supportive care in pancreatic cancer: A review. Biomedicines  2023,11(10),2690","journal-title":"Biomedicines"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/biom11101469","volume":"11","author":"Schlick K.","year":"2021","unstructured":"Schlick K.; Kiem D.; Greil R.; Recent advances in pancreatic cancer: Novel prognostic biomarkers and targeted therapy-a review of the literature. Biomolecules  2021,11(10),1469","journal-title":"Biomolecules"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.3390\/cancers14235725","volume":"14","author":"Liu J.","year":"2022","unstructured":"Liu J.; Lee P.; McGee H.M.; Chung V.; Melstrom L.; Singh G.; Raoof M.; Amini A.; Chen Y.J.; Williams T.M.; Advances in radiation oncology for pancreatic cancer: An updated review. Cancers  2022,14(23),5725","journal-title":"Cancers"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/cco-21-174","volume":"11","author":"Rangelova E.","year":"2022","unstructured":"Rangelova E.; Kaipe H.; Immunotherapy in pancreatic cancer\u2014an emerging role: A narrative review. Chin Clin Oncol  2022,11(1),4","journal-title":"Chin Clin Oncol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.18632\/aging.204310","volume":"14","author":"Jiang S.","year":"2022","unstructured":"Jiang S.; Fagman J.B.; Ma Y.; Liu J.; Vihav C.; Engstrom C.; Liu B.; Chen C.; A comprehensive review of pancreatic cancer and its therapeutic challenges. Aging  2022,14(18),7635-7649","journal-title":"Aging"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/nu14030619","volume":"14","author":"Triantafillidis J.K.","year":"2022","unstructured":"Triantafillidis J.K.; Triantafyllidi E.; Sideris M.; Pittaras T.; Papalois A.E.; Herbals and plants in the treatment of pancreatic cancer: A systematic review of experimental and clinical studies. Nutrients  2022,14(3),619","journal-title":"Nutrients"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2129884","DOI":"10.1080\/08941939.2022.2129884","volume":"36","author":"Kolbeinsson H.M.","year":"2023","unstructured":"Kolbeinsson H.M.; Chandana S.; Wright G.P.; Chung M.; Pancreatic cancer: A review of current treatment and novel therapies. J Invest Surg  2023,36(1),2129884","journal-title":"J Invest Surg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"zrad052","DOI":"10.1093\/bjsopen\/zrad052","volume":"7","author":"Willink C.Y.","year":"2023","unstructured":"Willink C.Y.; Jenniskens S.F.M.; Klaassen N.J.M.; Stommel M.W.J.; Nijsen J.F.W.; Intratumoral injection therapies for locally advanced pancreatic cancer: Systematic review. BJS Open  2023,7(3),zrad052","journal-title":"BJS Open"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12876-023-02853-w","volume":"23","author":"Petrelli F.","year":"2023","unstructured":"Petrelli F.; Parisi A.; Tomasello G.; Mini E.; Arru M.; Russo A.; Garrone O.; Khakoo S.; Ardito R.; Ghidini M.; Comparison of different second line treatments for metastatic pancreatic cancer: A systematic review and network meta-analysis. BMC Gastroenterol  2023,23(1),212","journal-title":"BMC Gastroenterol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e46630","DOI":"10.7759\/cureus.46630","volume":"15","author":"Awais N.","year":"2023","unstructured":"Awais N.; Satnarine T.; Ahmed A.; Haq A.; Patel D.; Hernandez G.N.; Seffah K.D.; Zaman M.A.; Khan S.; A systematic review of chemotherapeutic regimens used in pancreatic cancer. Cureus  2023,15(10),e46630","journal-title":"Cureus"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1186\/s12885-023-11207-4","volume":"23","author":"Salazar J.","year":"2023","unstructured":"Salazar J.; Bracchiglione J.; Savall-Esteve O.; Antequera A.; Bottaro-Parra D.; Guti\u00e9rrez-Valencia M.; Mart\u00ednez-Peralta S.; Pericay C.; Tibau A.; Bonfill X.; Acosta-Dighero R.; Auladell-Rispau A.; Cantero-Fortiz Y.; Hernandez E.; Irassar J.; Meade A-G.; Meinardi P.; Merch\u00e1n-Galvis A.; Meza N.; Quintana M.J.; Requeijo C.; Rodriguez-Grijalva G.; Salas-Gama K.; Santero M.; Savall-Esteve O.; Selva A.; Sol\u00e0 I.; Urr\u00fatia G.; Treatment with anticancer drugs for advanced pancreatic cancer: A systematic review. BMC Cancer  2023,23(1),748","journal-title":"BMC Cancer"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1111\/bph.13505","volume":"173","author":"Grolla A.A.","year":"2016","unstructured":"Grolla A.A.; Travelli C.; Genazzani A.A.; Sethi J.K.; Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine. Br J Pharmacol  2016,173(14),2182-2194","journal-title":"Br J Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"106189","DOI":"10.1016\/j.biocel.2022.106189","volume":"145","author":"Gasparrini M.","year":"2022","unstructured":"Gasparrini M.; Audrito V.; NAMPT: A critical driver and therapeutic target for cancer. Int J Biochem Cell Biol  2022,145,106189","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fonc.2018.00622","volume":"8","author":"Yaku K.","year":"2018","unstructured":"Yaku K.; Okabe K.; Hikosaka K.; Nakagawa T.; NAD metabolism in cancer therapeutics. Front Oncol  2018,8,622","journal-title":"Front Oncol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/0008-5472.CAN-09-2465","volume":"70","author":"Gall\u00ed M.","year":"2010","unstructured":"Gall\u00ed M.; Van Gool F.; Rongvaux A.; Andris F.; Leo O.; The nicotinamide phosphoribosyltransferase: A molecular link between metabolism, inflammation, and cancer. Cancer Res  2010,70(1),8-11","journal-title":"Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.1021\/jm4001049","volume":"56","author":"Galli U.","year":"2013","unstructured":"Galli U.; Travelli C.; Massarotti A.; Fakhfouri G.; Rahimian R.; Tron G.C.; Genazzani A.A.; Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. J Med Chem  2013,56(16),6279-6296","journal-title":"J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2174\/1389450111314060003","volume":"14","author":"Montecucco B.F.","year":"2013","unstructured":"Montecucco B.F.; Cea M.; Bauer I.; Soncini D.; Caffa I.; Lasigli\u00e8 D.; Nahimana A.; Uccelli A.; Bruzzone S.; Nencioni A.; Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: Rationales, controversies, clinical experience. Curr Drug Targets  2013,14(6),637-643","journal-title":"Curr Drug Targets"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pharmthera.2015.02.004","volume":"151","author":"Sampath D.","year":"2015","unstructured":"Sampath D.; Zabka T.S.; Misner D.L.; O\u2019Brien T.; Dragovich P.S.; Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer. Pharmacol Ther  2015,151,16-31","journal-title":"Pharmacol Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fphar.2020.00656","volume":"11","author":"Galli U.","year":"2020","unstructured":"Galli U.; Colombo G.; Travelli C.; Tron G.C.; Genazzani A.A.; Grolla A.A.; Recent advances in NAMPT inhibitors: A novel immunotherapic strategy. Front Pharmacol  2020,11,656","journal-title":"Front Pharmacol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fonc.2019.01514","volume":"9","author":"Heske C.M.","year":"2020","unstructured":"Heske C.M.; Beyond energy metabolism: Exploiting the additional roles of NAMPT for cancer therapy. Front Oncol  2020,9,1514","journal-title":"Front Oncol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/nu13051665","volume":"13","author":"Ghanem M.S.","year":"2021","unstructured":"Ghanem M.S.; Monacelli F.; Nencioni A.; Advances in NAD-lowering agents for cancer treatment. Nutrients  2021,13(5),1665","journal-title":"Nutrients"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"970553","DOI":"10.3389\/fphar.2022.970553","volume":"13","author":"Wei Y.","year":"2022","unstructured":"Wei Y.; Xiang H.; Zhang W.; Review of various NAMPT inhibitors for the treatment of cancer. Front Pharmacol  2022,13,970553","journal-title":"Front Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1021\/acs.bioconjchem.2c00178","volume":"33","author":"B\u00f6hnke N.","year":"2022","unstructured":"B\u00f6hnke N.; Berger M.; Griebenow N.; Rottmann A.; Erkelenz M.; Hammer S.; Berndt S.; G\u00fcnther J.; Wengner A.M.; Stelte-Ludwig B.; Mahlert C.; Greven S.; Dietz L.; J\u00f6ri\u00dfen H.; Barak N.; B\u00f6mer U.; Hillig R.C.; Eberspaecher U.; Weiske J.; Giese A.; Mumberg D.; Nising C.F.; Weinmann H.; Sommer A.; A novel NAMPT inhibitor-based antibody-drug conjugate payload class for cancer therapy. Bioconjug Chem  2022,33(6),1210-1221","journal-title":"Bioconjug Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"115607","DOI":"10.1016\/j.ejmech.2023.115607","volume":"258","author":"Tang H.","year":"2023","unstructured":"Tang H.; Wang L.; Wang T.; Yang J.; Zheng S.; Tong J.; Jiang S.; Zhang X.; Zhang K.; Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery. Eur J Med Chem  2023,258,115607","journal-title":"Eur J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/cmdc.200700311","volume":"3","author":"Galli U.","year":"2008","unstructured":"Galli U.; Ercolano E.; Carraro L.; Blasi Roman C.R.; Sorba G.; Canonico P.L.; Genazzani A.A.; Tron G.C.; Billington R.A.; Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage. ChemMedChem  2008,3(5),771-779","journal-title":"ChemMedChem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1021\/jm400186h","volume":"56","author":"Zheng X.","year":"2013","unstructured":"Zheng X.; Bauer P.; Baumeister T.; Buckmelter A.J.; Caligiuri M.; Clodfelter K.H.; Han B.; Ho Y.C.; Kley N.; Lin J.; Reynolds D.J.; Sharma G.; Smith C.C.; Wang Z.; Dragovich P.S.; Oh A.; Wang W.; Zak M.; Gunzner-Toste J.; Zhao G.; Yuen P.; Bair K.W.; Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors. J Med Chem  2013,56(12),4921-4937","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1021\/jm4008664","volume":"56","author":"Zheng X.","year":"2013","unstructured":"Zheng X.; Bauer P.; Baumeister T.; Buckmelter A.J.; Caligiuri M.; Clodfelter K.H.; Han B.; Ho Y.C.; Kley N.; Lin J.; Reynolds D.J.; Sharma G.; Smith C.C.; Wang Z.; Dragovich P.S.; Gunzner-Toste J.; Liederer B.M.; Ly J.; O\u2019Brien T.; Oh A.; Wang L.; Wang W.; Xiao Y.; Zak M.; Zhao G.; Yuen P.; Bair K.W.; Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors. J Med Chem  2013,56(16),6413-6433","journal-title":"J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"9071","DOI":"10.1021\/jm4009949","volume":"56","author":"Christensen M.K.","year":"2013","unstructured":"Christensen M.K.; Erichsen K.D.; Olesen U.H.; Tj\u00f8rnelund J.; Fristrup P.; Thougaard A.; Nielsen S.J.; Sehested M.; Jensen P.B.; Loza E.; Kalvinsh I.; Garten A.; Kiess W.; Bj\u00f6rkling F.; Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship. J Med Chem  2013,56(22),9071-9088","journal-title":"J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1021\/acs.jmedchem.6b01392","volume":"60","author":"Travelli C.","year":"2017","unstructured":"Travelli C.; Aprile S.; Rahimian R.; Grolla A.A.; Rogati F.; Bertolotti M.; Malagnino F.; di Paola R.; Impellizzeri D.; Fusco R.; Mercalli V.; Massarotti A.; Stortini G.; Terrazzino S.; Del Grosso E.; Fakhfouri G.; Troiani M.P.; Alisi M.A.; Grosa G.; Sorba G.; Canonico P.L.; Orsomando G.; Cuzzocrea S.; Genazzani A.A.; Galli U.; Tron G.C.; Identification of novel triazole-based Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitors endowed with antiproliferative and antiinflammatory activity. J Med Chem  2017,60(5),1768-1792","journal-title":"J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1158\/1535-7163.MCT-18-0643","volume":"17","author":"Neumann C.S.","year":"2018","unstructured":"Neumann C.S.; Olivas K.C.; Anderson M.E.; Cochran J.H.; Jin S.; Li F.; Loftus L.V.; Meyer D.W.; Neale J.; Nix J.C.; Pittman P.G.; Simmons J.K.; Ulrich M.L.; Waight A.B.; Wong A.; Zaval M.C.; Zeng W.; Lyon R.P.; Senter P.D.; Targeted delivery of cytotoxic nampt inhibitors using antibody-drug conjugates. Mol Cancer Ther  2018,17(12),2633-2642","journal-title":"Mol Cancer Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acsmedchemlett.8b00254","volume":"9","author":"Karpov A.S.","year":"2018","unstructured":"Karpov A.S.; Abrams T.; Clark S.; Raikar A.; D\u2019Alessio J.A.; Dillon M.P.; Gesner T.G.; Jones D.; Lacaud M.; Mallet W.; Martyniuk P.; Meredith E.; Mohseni M.; Nieto-Oberhuber C.M.; Palacios D.; Perruccio F.; Piizzi G.; Zurini M.; Bialucha C.U.; Nicotinamide phosphoribosyltransferase inhibitor as a novel payload for antibody-drug conjugates. ACS Med Chem Lett  2018,9(8),838-842","journal-title":"ACS Med Chem Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"111576","DOI":"10.1016\/j.ejmech.2019.111576","volume":"181","author":"Travelli C.","year":"2019","unstructured":"Travelli C.; Aprile S.; Mattoteia D.; Colombo G.; Clemente N.; Scanziani E.; Terrazzino S.; Alisi M.A.; Polenzani L.; Grosa G.; Genazzani A.A.; Tron G.C.; Galli U.; Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group. Eur J Med Chem  2019,181,111576","journal-title":"Eur J Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/molecules28041897","volume":"28","author":"Biniecka P.","year":"2023","unstructured":"Biniecka P.; Matsumoto S.; Belotti A.; Joussot J.; Bai J.F.; Majjigapu S.R.; Thoueille P.; Spaggiari D.; Desfontaine V.; Piacente F.; Bruzzone S.; Cea M.; Decosterd L.A.; Vogel P.; Nencioni A.; Duchosal M.A.; Nahimana A.; Anticancer activities of novel nicotinamide phosphoribosyltransferase inhibitors in hematological malignancies. Molecules  2023,28(4),1897","journal-title":"Molecules"},{"key":"ref=41","first-page":"7436","volume":"63","author":"Hasmann M.","year":"2003","unstructured":"Hasmann M.; Schemainda I.; FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res  2003,63(21),7436-7442","journal-title":"Cancer Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nsmb1105","volume":"13","author":"Khan J.A.","year":"2006","unstructured":"Khan J.A.; Tao X.; Tong L.; Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat Struct Mol Biol  2006,13(7),582-588","journal-title":"Nat Struct Mol Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/pharmaceutics15051472","volume":"15","author":"Conforti I.","year":"2023","unstructured":"Conforti I.; Benzi A.; Caffa I.; Bruzzone S.; Nencioni A.; Marra A.; Iminosugar-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as potential anti-pancreatic cancer agents. Pharmaceutics  2023,15(5),1472","journal-title":"Pharmaceutics"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"158819","DOI":"10.1016\/j.bbalip.2020.158819","volume":"1866","author":"Benzi A.","year":"2021","unstructured":"Benzi A.; Sturla L.; Heine M.; Fischer A.W.; Spinelli S.; Magnone M.; Sociali G.; Parodi A.; Fenoglio D.; Emionite L.; Koch-Nolte F.; Mittr\u00fccker H.W.; Guse A.H.; De Flora A.; Zocchi E.; Heeren J.; Bruzzone S.; CD38 downregulation modulates NAD+ and NADP(H) levels in thermogenic adipose tissues. Biochim Biophys Acta Mol Cell Biol Lipids  2021,1866(1),158819","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"9285","DOI":"10.1021\/jacs.0c00861","volume":"142","author":"Fiala T.","year":"2020","unstructured":"Fiala T.; Wang J.; Dunn M.; \u0160ebej P.; Choi S.J.; Nwadibia E.C.; Fialova E.; Martinez D.M.; Cheetham C.E.; Fogle K.J.; Palladino M.J.; Freyberg Z.; Sulzer D.; Sames D.; Chemical targeting of voltage sensitive dyes to specific cells and molecules in the brain. J Am Chem Soc  2020,142(20),9285-9301","journal-title":"J Am Chem Soc"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1021\/acs.joc.8b02862","volume":"84","author":"Fu L.Y.","year":"2019","unstructured":"Fu L.Y.; Ying J.; Qi X.; Peng J.B.; Wu X.F.; Palladium-catalyzed carbonylative synthesis of isoindolinones from benzylamines with TFBen as the CO source. J Org Chem  2019,84(3),1421-1429","journal-title":"J Org Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"7123","DOI":"10.1021\/jo0505472","volume":"70","author":"Grandjean C.","year":"2005","unstructured":"Grandjean C.; Boutonnier A.; Guerreiro C.; Fournier J.M.; Mulard L.A.; On the preparation of carbohydrate-protein conjugates using the traceless Staudinger ligation. J Org Chem  2005,70(18),7123-7132","journal-title":"J Org Chem"},{"year":"2018","author":"Vogel P.","key":"ref=48","unstructured":"Vogel P.; Duchosal M.; Nahimana A.; Robina I.; Mollinedo F.; Nencioni A.; Piperidine derivatives for use in the treatment of pancreatic cancer.  2018"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"23586","DOI":"10.1021\/acsami.7b08534","volume":"9","author":"Li F.","year":"2017","unstructured":"Li F.; Li Y.; Zhou Z.; Lv S.; Deng Q.; Xu X.; Yin L.; Engineering the aromaticity of cationic helical polypeptides toward \u201cself-activated\u201d DNA\/siRNA delivery. ACS Appl Mater Interfaces  2017,9(28),23586-23601","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/jm9010669","volume":"53","author":"Colombano G.","year":"2010","unstructured":"Colombano G.; Travelli C.; Galli U.; Caldarelli A.; Chini M.G.; Canonico P.L.; Sorba G.; Bifulco G.; Tron G.C.; Genazzani A.A.; A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry. J Med Chem  2010,53(2),616-623","journal-title":"J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"114504","DOI":"10.1016\/j.ejmech.2022.114504","volume":"239","author":"Bai J.F.","year":"2022","unstructured":"Bai J.F.; Majjigapu S.R.; Sordat B.; Poty S.; Vogel P.; El\u00edas-Rodr\u00edguez P.; Moreno-Vargas A.J.; Carmona A.T.; Caffa I.; Ghanem M.; Khalifa A.; Monacelli F.; Cea M.; Robina I.; Gajate C.; Mollinedo F.; Bellotti A.; Nahimana A.; Duchosal M.; Nencioni A.; Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer. Eur J Med Chem  2022,239,114504","journal-title":"Eur J Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"115170","DOI":"10.1016\/j.ejmech.2023.115170","volume":"250","author":"Fratta S.","year":"2023","unstructured":"Fratta S.; Biniecka P.; Moreno-Vargas A.J.; Carmona A.T.; Nahimana A.; Duchosal M.A.; Piacente F.; Bruzzone S.; Caffa I.; Nencioni A.; Robina I.; Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer. Eur J Med Chem  2023,250,115170","journal-title":"Eur J Med Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev  2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064289584240121142405","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226778\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064289584240121142405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T06:24:47Z","timestamp":1726813487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226778\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064289584240121142405","relation":{},"ISSN":["1573-4064"],"issn-type":[{"type":"print","value":"1573-4064"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}